Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2005-8-17
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E2
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16106014-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16106014-Bone Marrow Transplantation, pubmed-meshheading:16106014-Burkitt Lymphoma, pubmed-meshheading:16106014-Clinical Trials as Topic, pubmed-meshheading:16106014-Combined Modality Therapy, pubmed-meshheading:16106014-Disease-Free Survival, pubmed-meshheading:16106014-Drug Administration Schedule, pubmed-meshheading:16106014-Hematologic Neoplasms, pubmed-meshheading:16106014-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:16106014-Humans, pubmed-meshheading:16106014-Leukemia, Myeloid, Acute, pubmed-meshheading:16106014-Lymphoma, Follicular, pubmed-meshheading:16106014-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:16106014-Lymphoma, Mantle-Cell, pubmed-meshheading:16106014-Multicenter Studies as Topic, pubmed-meshheading:16106014-Multiple Myeloma, pubmed-meshheading:16106014-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:16106014-Prospective Studies, pubmed-meshheading:16106014-Randomized Controlled Trials as Topic, pubmed-meshheading:16106014-Survival Analysis, pubmed-meshheading:16106014-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Third biannual report of the Cochrane Haematological Malignancies Group.
pubmed:affiliation
Cochrane Haematological Malignancies Group, Cologne, Germany. thilo.kober@medizin.uni-koeln.de
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't